Inventor
DIPIETRO LUCIAN V
US26 patents
⚠️ This page may combine multiple inventors who share the name “DIPIETRO LUCIAN V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BLUEPRINT MEDICINES CORP
12 patentsUS10584114B2Mar 10, 2020
Inhibitors of RET
BLUEPRINT MEDICINES CORP13 citations94
US10202365B2Feb 12, 2019
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
BLUEPRINT MEDICINES CORP20 citations94
US10035789B2Jul 31, 2018
Compounds useful for treating disorders related to RET
BLUEPRINT MEDICINES CORP31 citations94
US10030005B2Jul 24, 2018
Inhibitors of RET
BLUEPRINT MEDICINES CORP38 citations94
US10000490B2Jun 19, 2018
Inhibitors of the fibroblast growth factor receptor
BLUEPRINT MEDICINES CORP30 citations94
US9994552B2Jun 12, 2018
Compositions useful for treating disorders related to kit
BLUEPRINT MEDICINES CORP31 citations94
US9695165B2Jul 4, 2017
Inhibitors of the fibroblast growth factor receptor
BLUEPRINT MEDICINES CORP40 citations94
US10227329B2Mar 12, 2019
Compounds useful for treating disorders related to RET
BLUEPRINT MEDICINES CORP19 citations85
US11279688B2Mar 22, 2022
Inhibitors of RET
BLUEPRINT MEDICINES CORP5 citations84
US10774070B2Sep 15, 2020
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
BLUEPRINT MEDICINES CORP6 citations84
US10221154B2Mar 5, 2019
Inhibitors of the fibroblast growth factor receptor
BLUEPRINT MEDICINES CORP11 citations84
US10875837B2Dec 29, 2020
Inhibitors of the fibroblast growth factor receptor
BLUEPRINT MEDICINES CORP1 citations73
AMGEN INC
6 patentsUS7282504B2Oct 16, 2007
Kinase inhibitors
AMGEN INC90 citations97
US6878714B2Apr 12, 2005
Substituted alkylamine derivatives and methods of use
AMGEN INC85 citations97
US7435823B2Oct 14, 2008
Compounds and methods of use
AMGEN INC19 citations92
US7102009B2Sep 5, 2006
Substituted amine derivatives and methods of use
AMGEN INC49 citations92
US7074789B2Jul 11, 2006
Kinase inhibitors
AMGEN INC25 citations92
US6864255B2Mar 8, 2005
Substituted triazinyl amide derivatives and methods of use
AMGEN INC10 citations73
RELAY THERAPEUTICS INC
4 patentsUS11629145B2Apr 18, 2023
SHP2 phosphatase inhibitors and methods of use thereof
RELAY THERAPEUTICS INC3 citations69
US11591336B2Feb 28, 2023
Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
RELAY THERAPEUTICS INC3 citations69
US12219327B2Feb 4, 2025
Substituted isoindolines as PI3K-alpha inhibitors
RELAY THERAPEUTICS INC1 citations60
US12581252B2Mar 17, 2026
Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors
RELAY THERAPEUTICS INC0 citations54